• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

When undergoing a nuclear heart scan, many patients are concerned about the level of radiation they will be exposed to. Understanding the concept of radiation dose can help alleviate some of this anxiety. The level of unknowns compared to the technology used during scans, however, often leaves patients worried.

ionizing radiation exposure, measured in units such as millisieverts (mSv) or milligrams of radiation absorbed (mGy), refers to the amount of electromagnetic radiation that passes through the human body. In a nuclear heart scan, also known as a myocardial perfusion scan, a small amount of radioisotope tracer is injected into the patient's bloodstream. This material, called a radiotracer, accumulates in areas with high blood flow, allowing the nuclear cardiologist to visualize the coronary arteries, determine the blood flow to heart muscle, and اسکن هسته ای قلب identify any potential lesions.

During the scan, the radiotracer emits a low dose of ionizing radiation. This dose is extremely low compared to the radiation exposure we receive daily from natural sources, such as cosmic rays, radon gas, and soil contamination. To put things into perspective, a single chest X-ray delivers around 0.1 millisieverts of radiation. In contrast, a nuclear heart scan typically uses a tracer substance that decays at a rate of 2-10 millisieverts per hour, but this decays over two to three hours after injection.

When we discuss the radiation dose from nuclear heart scans, we don't just measure the amount of radiation received from the scan itself; we also consider the amount received from the tracer material as it decays over time. Taking into account these total effective doses, most patients who undergo a nuclear heart scan receive a dose equivalent to about 10-20 mSv. For a comparison, a typical person living in a moderate climate receives about 2.4 millisieverts of natural background radiation each year.

Despite these low radiation doses, there are some serious risks surrounding radiation exposure and public health. For instance, high levels of occupational exposure, resulting from activities like radiation therapy for cancer or nuclear power plant operations, can significantly increase cancer risk in those exposed. Research suggests that there may be a risk of cancer in people who receive high doses of radiation, but lower doses like those obtained with nuclear heart scans do not appear to be associated with an increased cancer risk.

While nuclear heart scans can provide valuable information for diagnosing heart conditions, it is essential for patients to be aware of their exposure to radiation. If patients have any specific concerns, discussing them with their healthcare provider is the best course of action. In some cases, patients may be prescribed low-radiation or alternative diagnostic procedures to perform the scan.

To mitigate such misperceptions and allay patients' anxiety about the potential health risks associated with nuclear heart scans, we continue to research and innovate the design of radiotracers, improving their safety and ability to provide essential health information. As a result, patients can be reassured that, with current technology, the risks associated with nuclear heart scans are extremely low, and the benefits they offer in terms of accurate diagnosis and optimal treatment should be weighed against any questions.